Top Pharma Companies Look to Partnerships and Acquisitions to Maximize Resources During Product Development & Commercialization

20:00 EDT 19 Jun 2017 | Marketwired

RESEARCH TRIANGLE PARK, NC--(Marketwired - June 20, 2017) - Research into medical device acquisitions revealed that many device manufacturers look to partnerships and acquisitions to move products from the laboratory to market, according to a study by business intelligence provider, Cutting Edge Information.

Data published in the study, Medical Device Development: Benchmarking Early-Stage Product Management and Promotion
, revealed that 60% of Top 10 pharmaceutical companies report developing and commercializing products via acquisitions. An additional 20% of the largest surveyed device makers look to collaborations.

Surveyed Top 50 and small medical device companies, 11% and 7% respectively, look to acquisitions to drive product development. Data from the same study show that 21% of small device firms also report using collaborations to drive product development.

"Medical device development and commercialization consume a lot of resources," said Adam Bianchi, senior director of research at Cutting Edge Information. "As such, many medical device manufacturers look to partnerships and collaboration to aid a number of processes in both product development and early commercialization."

The study found that in some cases, companies may work together to develop and support a single brand. For example, one company reported working with another parent company in a true partnership, where they developed and manufactured the product while its partner took on the cost of testing and commercializing the device.

Medical device manufacturers use acquisitions to gain technology, intellectual property or complete businesses. Among the surveyed companies reporting acquisitions, half gained whole companies or technology.

However, medical device companies must be cautious before buying these new technologies. Firms should always be aware of the potential problems for which they will be liable in the future. One interviewed executive cautions, "If it's a technical product -- one that would be FDA-regulated -- you should go into a company like you're the FDA. You dig and find all of the problems because, if you do buy the company, you're going to have to explain to the FDA why [the problems] haven't been fixed."

Medical Device Development: Benchmarking Early-Stage Product Management and Promotion
, available at, explores the resources and best practices necessary to support new product planning and commercialization for US-based medical device launches. This benchmarking study, conducted through primary research, includes:

To learn more about Cutting Edge Information's primary benchmarking research on medical device development and commercialization, or other life sciences topics, please download the brochure at:

Image Available: Image Available:

CONTACT: Elio Evangelista Senior Director of Commercialization Cutting Edge Information 919-403-6583 NEXT ARTICLE

More From BioPortfolio on "Top Pharma Companies Look to Partnerships and Acquisitions to Maximize Resources During Product Development & Commercialization"

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.